Liam Ratcliffe

Affiliations

  • Director at Arvinas Inc. (ARVN), 2022-06-22
  • Director at Eliem Therapeutics Inc. (ELYM), 2022-06-01
  • Director at Passage Bio Inc. (PASG), 2021-05-28
  • Director at Unum Therapeutics Inc. (UMRX), 2019-06-18
  • Director at Aptinyx Inc. (APTX), 2019-04-02
  • Director at Edge Therapeutics Inc. (EDGE), 2019-03-18
  • Large Shareholder at Iterum Therapeutics Plc (ITRM), 2018-05-31
  • Large Shareholder, Director at Deciphera Pharmaceuticals Inc. (DCPH), 2018-05-21
  • Large Shareholder at Irhythm Technologies Inc. (IRTC), 2016-10-25
  • Large Shareholder at Mei Pharma Inc. (MEIP), 2015-03-26
  • Large Shareholder at Versartis Inc. (VSAR), 2014-12-22
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-11-18
  • Large Shareholder at Chimerix Inc (CMRX), 2014-03-20
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-02-21
  • Other at Oxford Immunotec Global Plc (OXFD), 2013-12-03
  • Other at Relypsa Inc (RLYP), 2013-11-21
  • Director at Array Biopharma Inc (ARRY), 2013-10-25
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ARVN $70.00 142,857 Director 822,857 2020-12-18 Filing
PASG $18.00 2,800 Director 2,800 2020-03-03 Filing
PASG $18.00 550,000 Director 2,616,630 2020-03-03 Filing
PASG $18.00 2,800 Director 2,800 2020-03-03 Filing
ARVN $22.00 680,000 Director 680,000 2019-11-12 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ARVN $68.97 37,206 Director 185,686 2021-12-16 Filing
ARVN $69.66 48,499 Director 222,892 2021-12-16 Filing
ARVN $65.74 5,695 Director 271,391 2021-12-15 Filing
ARVN $66.50 67,549 Director 277,086 2021-12-15 Filing
ARVN $67.46 40,292 Director 344,635 2021-12-15 Filing